Post-test for Obesity medications symposium: what, why, how?
Presented by Dietitian Connection on November 20, 2024

CPEU webinar post-test

Privacy Collection Statement

The purpose of this statement is to advise you that we may collect, use and disclose various personal information about you, for the purposes of providing services to you, facilitating our internal business operations, including the fullfilment of any legal and regulatory requirements and providing you with information about us and the services that we offer. More detailed information about the way we use, disclose and secure your personal information, and how you can access that information, can be found in our privacy policy, available on the Dietitian Connection website or by contacting us using our details shown on the website.

Question Title

* 1. How do obesity medications help with appetite regulation?

Through action in the gastrointestinal system

Through action in the brain via the physiological hunger centre

Through action in the brain via the hedonistic hunger centre

All of the above

Question Title

* 2. Check all that apply: How are the current obesity medications being used?

Obesity management

Type 2 diabetes management

The management of health concerns associated with higher body weight

Question Title

* 3. What are the potential side effects of these medications?

Reduced appetite

Nausea and vomiting

Constipation or Diarrhea

Dehydration

All of the above

Question Title

* 4. Are clients typically exploring obesity medications for physical or psychosocial goals?

Physical goals (e.g. Fitness, health)

Psychosocial goals (e.g. Body image, social life)

Both

Neither